Advertisement
Screener

RELMADA THERAPEUTICS, INC. (RLMD) Class of Warrant or Right, Outstanding

2.9 / 5 stars · 23/40 Roast Me

RELMADA THERAPEUTICS, INC. Class of Warrant or Right, Outstanding

RELMADA THERAPEUTICS, INC. (RLMD) had Class of Warrant or Right, Outstanding of 5.42 thousand shares as of 2022-09-30, per its 10-Q filed 2022-11-10.

Discontinued › Notes › Other Liabilities

us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2022-11-10

  • 2022-09-30: Class of Warrant or Right, Outstanding 5.42K shares.
  • 2022-03-31: Class of Warrant or Right, Outstanding 73.27K shares.
  • 2021-09-30: Class of Warrant or Right, Outstanding 29.28K shares.
  • 2021-06-30: Class of Warrant or Right, Outstanding 4.17K shares.
Period endClass of Warrant or Right, OutstandingClass of Warrant or Right, Outstanding as first filed
2022-09-305.42K shares
10-Q · filed 2022-11-10
2022-03-3173.27K shares
10-Q · filed 2022-05-05
2021-09-3029.28K shares
10-Q · filed 2021-11-12
2021-06-304.17K shares
10-Q · filed 2021-08-10
2021-03-3148.18K shares
10-Q · filed 2021-05-12
2020-09-3052.27K shares
10-Q · filed 2020-11-12
2019-09-30327.57K shares
10-Q · filed 2019-11-13
2014-06-305.88M shares
10-KT · filed 2014-09-09
2013-12-318.93M shares
10-KT · filed 2014-09-09
89.27M shares
8-K · filed 2014-05-27
2012-12-314.87M shares
10-KT · filed 2014-09-09
48.65M shares
8-K · filed 2014-05-27
2011-12-316.25K shares
10-KT · filed 2014-09-09
62.51K shares
8-K · filed 2014-05-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Rezolute, Inc. (RZLT)United States$0.382B-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63